NHS ester of 2H,2H,3H
,3H-perfluorodecanoic acid [3] . 
Chemicals and instrumentation
Chemicals were purchased from Sigma Aldrich, Fluorochem, Novabiochem, Bachem or P&M-Invest and used as received unless otherwise noted. UPLC experiments were performed with an Acquity UPLC H Class Bio from Waters equipped with a PDA and a SQ detector 2 with the following column: ACQUITY UPLC, HSS T3 1.8 µm, 2.1 x 100 mm. Solvents were water and acetonitrile, respectively, each containing 0.1 % formic acid, later on referred to as (A) and (B). The flow rate was set to 0.61 ml/min and the temperature to 40 °C. Method 1: 0 min -100% A; 1 min -100% A; 3 min -80% A; 13.5 min -20% A. -hydroxysuccinimide; HSTU = N,N,N',N'-tetramethyl-O-(N-succinimidyl) uronium hexafluorophosphate, HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol. General procedure 1: Ala-Trp-Ala 1 [1] 2-Chlorotrityl chloride resin (1 mmol/g, 700 mg) was placed in a plastic syringe equipped with a filter frit. The resin was washed with CH 2 Cl 2 (4 ml). Subsequently the syringe was filled with CH 2 Cl 2 (4 ml) and placed on a shaker for 15 min. The CH 2 Cl 2 was exchanged and DIPEA (6.0 eq, 0.70 ml, 4.2 mmol), and Fmoc-ala-OH (2.00 eq., 436 mg, 1.40 mmol) were added. Note: equivalents refer to chlorotrityl groups on the resin (1 mmol/g). After the sample was agitated on a shaker for 1.5 h the reaction mixture was removed and the resin was washed with CH 2 Cl 2 (4 ml) and DMF (4 ml). The unreacted binding sites on the resin were capped by adding MeOH-solution (5 ml, 15% MeOH, 5% DIPEA, 80% CH 2 Cl 2 ) followed by 15 min agitation. Subsequently the sample was washed with CH 2 Cl 2 (4 ml) and DMF (4 ml). Next Fmoc deprotection solution (20 % piperidine in DMF) was added and shaking continued for 5 mins. This step was repeated three times. Note: In the following this procedure will be referred to as Fmoc deprotection.
The sample was washed with DMF (4 ml) and CH 2 Cl 2 (4 ml) and again with DMF (4 ml). Between the different washing steps the sample was agitated on the shaker for 30 sec. Note: In the following this procedure will be referred to as washing. After the washing DMF (4 ml), DIPEA (6.0 eq, 0.70 ml, 4.2 mmol), Fmoc-Trp(Boc)-OH (2.00 eq. 737 mg, 1.40 mmol) and PyBOP (2.00 eq., 729 mg, 1.40 mmol) were added. The mixture was agitated on a shaker for 2 h. Note: In the following this procedure will be referred to as peptide coupling. This was followed by washing, Fmoc deprotection and another washing. For the next peptide coupling DIPEA (6.0 eq., 0.70 ml, 4.2 mmol), Fmoc-Ala-OH (2.00 eq., 436 mg, 1.40 mmol) and PyBOP (2.00 eq., 729 mg, 1.40 mmol) were used. After washing, Fmoc-deprotection and another washing the resin was rinsed with CH 2 Cl 2 (3  4 ml) before the cleavage solution (5 ml, 96 % TFA, 3 % triisopropylsilane, 3 % H 2 O ) was added. For the cleavage procedure the mixture was agitated on the shaker for 1 h. Subsequently the cleavage solution was removed and the resin washed with TFA (1 ml General procedure 2: Ac-Ala-Trp-Ala-NH 2
Rink amid resin (0.54 mmol/g, 900 mg) was placed in a plastic syringe equipped with a filter frit. The resin was washed with CH 2 Cl 2 (4 ml). Then CH 2 Cl 2 (4 ml) was added and the syringe placed on a shaker for 15 min. Subsequently DMF (4 ml), DIPEA (6.0 eq, 0.48 ml, 2.9 mmol), Fmoc-ala-OH (3.01 eq., 455 mg, 1.46 mmol) and PyBOP (3.00 eq., 760 mg, 1.46 mmol) were added. Note: Equivalents refer to the amine groups on the resin (0.54 mmol/g). The syringe was placed on a shaker and the mixture agitated for 2 h. In the following this procedure will be referred to as peptide coupling. Peptide coupling was followed by washing, Fmoc deprotection and another washing. The second peptide coupling was performed with DIPEA (6.0 eq, 0.48 ml, 2.9 mmol), Fmoc-Trp(Boc)-OH (3.00 eq., 769 mg, 1.46 mmol) and PyBOP (3.00 eq., 760 mg, 1.46 mmol) followed by washing, Fmoc deprotection and another washing. The last peptide coupling was performed with DIPEA (6.0 eq, 0.48 ml, 2.9 mmol), Fmoc-Ala-OH (3.01 eq., 455 mg, 1.46 mmol) and PyBOP (3.00 eq., 760 mg, 1.46 mmol). After washing, Fmoc deprotection and another washing, capping solution (4 ml, 10 % acetic anhydride in DMF) and DIPEA (0.5 ml) were added and the mixture agitated for 5 min. The capping step was repeated once. After another washing the resin was rinsed with CH 2 Cl 2 (3  4 ml) before the cleavage solution (5 ml, 96 % TFA, 3 % triisopropylsilane, 3 % H 2 O ) was added. For the cleavage procedure the mixture was agitated on the shaker for 1 h. Subsequently the cleavage solution was collected and the resin washed with TFA (1 ml General procedure 3:
NaH (25.0 eq., 465 mg, 19.4 mmol) was added to DMSO (14 mL). The suspension was heated to 90 °C for 60 min (until H 2 formation ceased) and allowed to cool to room temperature. The formed dimsylsolution was added to a solution of Ac-Ala-Trp-Ala-NH 2 (1.00 eq., 300 mg, 0.774 mmol) in DMSO (5 ml). After 2 min methyl iodide (75.0 eq., 3.61 ml, 58.1 mmol) was added slowly under strong stirring. After 2 h H 2 O (50 ml) was added to the reaction mixture and stirring continued for another 10 minutes. The product was extracted with chloroform (30 ml, 2  15 ml). The combined organic layers were washed with brine (2  25 ml) and H 2 O (2  25 ml). The solvent was removed by means of a rotary evaporator and the crude product obtained as a brown oil. The product was purified by means of preparative HPLC using an isocratic flow of water (0.1 % TFA) /acetonitrile (0.1 % TFA) in a ratio of 75:25 with a flow rate of 19 ml (T R = 11 min. (2H,2H,3H,3H-perfluorooctanoyl)-Ala-Trp-Ala-NH 2 3
The synthesis was performed in analogy to general procedure 2. Rink amid resin (900 mg) was placed in a plastic syringe equipped with a filter frit. The resin was washed with CH 2 Cl 2 (4 ml). Subsequently CH 2 Cl 2 (4 ml) was added and the mixture agitated on a shaker for 15 min. Peptide coupling was performed with Fmoc-Ala-OH (3.01 eq., 455 mg, 1.46 mmol) and the respective reagents as described for the Rink amid resin procedure above. Note: The equivalents refer to the amine groups on the resin (0.54 mmol/g). (2H,2H,3H,3H-perfluorooctanoyl)-Ala-Trp-Ala
The synthesis was performed in analogy to general procedure 1 with the following quantities for the loading of the resin: 2-chlorotrityl chloride resin (700 mg), DIPEA (6.0 eq, 0.70 ml, 4.2 mmol), and Fmocala-OH (2.00 eq., 436 mg, 1.40 mmol) were added. Note: The equivalents refer to the chlorotrityl groups on the resin. After the sample was agitated on a shaker for 1.5 h liquids were removed by filtration and the resin washed with CH 2 Cl 2 (4 ml) and DMF (4 ml). 
The dimsyl-anion was prepared in identical quantities and concentrations as described above for compound 2 and combined with a solution of (2H,2H,3H,3H-perfluorooctanoyl)-Ala-Trp-Ala-NH 2 (1.00 eq., 516 mg, 0.770 mmol) in DMSO (5 ml). Addition of MeI (75 eq., 3.6 ml, 58 mmol), quench with water, extraction and purification were performed as described above. The product was isolated as a pale brown oil (183 mg, 0.243 mmol, 31 %). (2H,2H,3H,3H-perfluoroundecanoyl)-Trp-Ala-Ala-(2H,2H,3H,3H-perfluorodecylamid) 7
UPLC-MS: Method 2, T R = 5.48 min; m/z MS (ES+): 624.3 [100%, M -(C-terminal
Identical procedure as for (2H,2H,3H,3H-perfluorooctanoyl)-Trp-Trp-Ala-(2H,2H,3H,3H-perfluorodecylamid) but employing (2H,2H,3H,3H-perfluoroundecanoyl)-Trp-Ala-Ala instead of (2H,2H,3H,3H-perfluorooctanoyl)-Ala-Trp-Ala. White powder (615 mg, 0.486 mmol, 40 %). NHS-ester of 2H,2H,3H,3H-perfluorodecanoic acid [3] 2H,2H,3H,3H-perfluorodecanoic acid (1.00 eq., 15.0 g, 30.5 mmol) was dissolved in THF (500 ml), then HSTU (1.50 eq., 13.8 g, 45.8 mmol) and DIPEA (1.49 eq., 7.50 ml, 45.4 mmol) were added and the solution was stirred overnight. The solvent was removed under reduced pressure and the crude product dissolved in EtOAc (1 l) and washed with 0.1 M HCl (2  200 ml), brine (200 ml) and H 2 O (200 ml). After removal of volatiles under reduced pressure the crude product was purified by column chromatography (EtOAc/cyclohexane (1:1)). The product was obtained as a white solid (16.1 g, 27.4 mmol, 90 %). Trp-Lys-Trp-Lys-Trp-Lys-Trp-Lys-Trp 2-chlorotrityl chloride resin (200 mg) was placed in a plastic syringe equipped with a filter frit. The CH 2 Cl 2 was exchanged and DIPEA (2.4 eq, 20 µl, 0.12 mmol), and Fmoc-Trp(boc)-OH (1.00 eq., 26.3 mg, 49.9 mol) were added. After the sample was agitated on a shaker for 2.5 h liquids were removed by filtration and the resin washed with CH 2 Cl 2 (4 ml) and DMF (4 ml). The unreacted binding sites on the resin were capped by adding MeOH-solution (5 ml, 15% MeOH, 5% DIPEA, 80% CH 2 Cl 2 ) followed by agitation for 30 minutes. The peptide coupling steps were performed using a (intavis multi pep RSI) peptide synthesizer and employing 5.00 eq. of Fmoc-amino acids, PyBOP and DIPEA with a reaction time of first 45 min followed be a 2 nd coupling step for 90 min. Fmoc-deprotection was carried out with piperidine (20 %, 4  5 min). In between coupling and Fmoc-deprotection the syringes were washed 5 times with DMF. In the end the syringe was washed with CH 2 Cl 2 (5  2 ml) before the cleavage solution (5ml, 96 % TFA, 3 % triisopropylsilane, 3 % H 2 O ) was added. Cleavage, precipitation and washing (Et 2 O) were performed as described above. The product was isolated as a white solid (64 mg, 44 mol, 88 %). 3.50-2.95 (m,18 H, H-15 and H-10), 2.60-2.25 (m, 20 H, H-1 and H-2), 1.77-1.41 (m, 8 H, H-7) , 1.41-1.25 (m, 8 H, H-8), 1.16-0.86 (m, 8 H, H-9) . 13 C (no HMBC experiment was recorded -carbon atoms without hydrogen substituents were not detected)  = 123.0 (C-23), 122.7 (C-23), 122.4 (3 C, C-23), 121.4 (5 C, C-19), 118.7 (5 C, C-18), 117.2 (C-17), 116.9 (2 C, C-17), 116.7 (2 C, C-17), 110.6 (5 C, C-20), 54.7 (C-6), 54.6 (C-6), 54.3 (C-6), 53.9 (2 C, C-5), 53.6 (2 C, C-5) , 53.4 (C-6), 52.5 (C-5), 38.4 (4 C, C-10), 29.2 (4 C, C-7) , 26.8 (C-8), 25.6 ( 10 C, C-1 and C-2) 
UPLC-MS

